← Back to Search

Other

Alcohol Effects on Anxiety in Latinos

N/A
Waitlist Available
Led By Andres G Viana, Ph.D.
Research Sponsored by University of Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
21-65 years of age
Be older than 18 years old
Must not have
Medical conditions that contraindicate the use of alcohol (e.g., diabetes, liver disease);
Active suicidality (i.e., suicidal ideation, intent, and/or plan) or current psychosis.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 minutes before alcohol administration.
Awards & highlights

Summary

This trial looks at how alcohol affects anxiety levels in Latino drinkers, and what cultural experiences play a role in these relationships.

Who is the study for?
This trial is for Latino adults aged 21-65 who are moderate or heavy drinkers, with an AUDIT score of at least 8. It's not for those who might be pregnant, on psychiatric or certain other meds, have a history of substance abuse treatment, current severe mental health issues, medical conditions worsened by alcohol like diabetes or liver disease, or high risk for drug problems.Check my eligibility
What is being tested?
The study looks at how alcohol affects anxiety levels in Latino drinkers and the role cultural experiences play. Participants will either receive alcohol to drink, no alcohol (abstain), or a placebo that doesn't contain any real alcohol. The effects on their anxiety after drinking will be compared.See study design
What are the potential side effects?
Since this trial involves the administration of alcohol to participants, potential side effects include typical reactions to alcohol such as dizziness, nausea, impaired coordination and judgment. Placebo should not cause any side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 21 and 65 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a condition like diabetes or liver disease that means I shouldn't drink alcohol.
Select...
I am not currently experiencing thoughts of harming myself or dealing with psychosis.
Select...
I am currently taking psychiatric medication or medication that should not be mixed with alcohol.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 minutes before alcohol administration, and 5 minutes after alcohol administration.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 minutes before alcohol administration, and 5 minutes after alcohol administration. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alcohol Urge Questionnaire (AUQ)
Amount of alcohol consumed in "standard drinks" (0.6 oz. ethanol equivalents, 12 oz. U.S. domestic beer, 5 oz. 12% alcohol table wine, 1.5 oz. 80-proof hard liquor)
State-Trait Anxiety Inventory, State Version (STAI-S)
Secondary outcome measures
Kulis, Marsiglia & Nieri's (2009) Substance Use Attitudes/Expectancies Scale

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Moderate AlcoholExperimental Treatment1 Intervention
Group II: Low AlcoholExperimental Treatment1 Intervention
Group III: No AlcoholActive Control1 Intervention
Group IV: Placebo AlcoholActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of HoustonLead Sponsor
148 Previous Clinical Trials
47,499 Total Patients Enrolled
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
815 Previous Clinical Trials
1,159,772 Total Patients Enrolled
Andres G Viana, Ph.D.Principal InvestigatorUniversity of Houston

Media Library

Alcohol (Other) Clinical Trial Eligibility Overview. Trial Name: NCT03807817 — N/A
Alcohol Consumption Research Study Groups: Low Alcohol, No Alcohol, Placebo Alcohol, Moderate Alcohol
Alcohol Consumption Clinical Trial 2023: Alcohol Highlights & Side Effects. Trial Name: NCT03807817 — N/A
Alcohol (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03807817 — N/A
~17 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top